Evidence map›Paper›PMID 19073888›Full record

ArticleMolecular biology of the cell2009

The NatA acetyltransferase couples Sup35 prion complexes to the [PSI+] phenotype.

John A Pezza, Sara X Langseth, Rochele Raupp Yamamoto, Stephen M Doris, Samuel P Ulin, Arthur R Salomon, Tricia R Serio

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Defining the limits: Protein aggregation and toxicity in vivo.Critical reviews in biochemistry and molecular biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

John A PezzaBrown University, Department of Molecular Biology, Cell Biology, and Biochemistry, Providence, RI 02912, USA.
Sara X Langseth
Rochele Raupp Yamamoto
Stephen M Doris
Samuel P Ulin
Arthur R Salomon
Tricia R Serio

Funding

Prion Cycle Regulation In VivoR01GM069802 · NIGMS · UNIVERSITY OF ARIZONA · PI SERIO, TRICIA R. · 2006 to 2014
$2.7M
Modulation of Translation Termination FidelityK01CA096402 · NCI · YALE UNIVERSITY · PI SERIO, TRICIA R · 2001 to 2005
$728k
In vivo analysis of Dynamic protein conformationsF32GM080907 · NIGMS · BROWN UNIVERSITY · PI PEZZA, JOHN ANTHONY · 2007 to 2009
$148k
NCI NIH HHS CA096402NCI NIH HHS K01 CA096402NIGMS NIH HHS F32 GM080907NIGMS NIH HHS GM069802NIGMS NIH HHS R01 GM069802
6 · The paper itself

Abstract

Protein-only (prion) epigenetic elements confer unique phenotypes by adopting alternate conformations that specify new traits. Given the conformational flexibility of prion proteins, protein-only inheritance requires efficient self-replication of the underlying conformation. To explore the cellular regulation of conformational self-replication and its phenotypic effects, we analyzed genetic interactions between [PSI(+)], a prion form of the S. cerevisiae Sup35 protein (Sup35([PSI+])), and the three N(alpha)-acetyltransferases, NatA, NatB, and NatC, which collectively modify approximately 50% of yeast proteins. Although prion propagation proceeds normally in the absence of NatB or NatC, the [PSI(+)] phenotype is reversed in strains lacking NatA. Despite this change in phenotype, [PSI(+)] NatA mutants continue to propagate heritable Sup35([PSI+]). This uncoupling of protein state and phenotype does not arise through a decrease in the number or activity of prion templates (propagons) or through an increase in soluble Sup35. Rather, NatA null strains are specifically impaired in establishing the translation termination defect that normally accompanies Sup35 incorporation into prion complexes. The NatA effect cannot be explained by the modification of known components of the [PSI(+)] prion cycle including Sup35; thus, novel acetylated cellular factors must act to establish and maintain the tight link between Sup35([PSI+]) complexes and their phenotypic effects.

Indexed as

AcetyltransferasesAmino Acid SequenceMolecular Sequence DataMutationPeptide Chain Termination, TranslationalPeptide Termination FactorsPhenotypePrionsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAcetyltransferasesNatA protein, S cerevisiaePeptide Termination FactorsPrionsSaccharomyces cerevisiae ProteinsSUP35 protein, S cerevisiae

Identifiers

PMID19073888
PMCPMC2633373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.